Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 January 2024 | Story André Damons | Photo Supplied
CHPC students read more
The top finishing UFS team, Team 5, consisting of Nhlonipho Shezi, Kgoboketso Mphahlele, Albert van Eck (mentor), Itumeleng Khaka, and Bophelo Pharasi came third during the national round of the National Integrated Cyber Infrastructure Systems (NICIS) CHPC’s Student Cluster Competition.

Two students from the University of the Free State (UFS) who took part in the National Integrated Cyber Infrastructure Systems (NICIS) CHPC Student Cluster Competition were selected as part of the National Team to compete at the International Supercomputing Conference (ISC) Student Cluster Competition next year.

Itumeleng Khaka and Nhlonipho Shezi, both currently studying towards a Bachelor of Science degree in Information Technology majoring in Computer Science and Business Management, were part of one of the university’s teams (Team 5) that took third place during the national round of the competition.

Bophelo Pharasi (Bachelor of Science in Information Technology majoring in Computer Science and Business Management) and Kgoboketso Mphahlele (Bachelor of Computer Information Systems) were the other team members, and Albert van Eck, Head of the eResearch and High-Performance Computing Unit, was their mentor. The UFS entered three teams for the competition. 

Another student, Limpho Senatla (Bachelor of Science in Information Technology), was awarded the prize for the female student with the most potential during this competition. Some of the prizes awarded to her include an opportunity to work under the mentorship of sponsors such as Tsolo.io, Diplomics, Intel, and the South African Radio Astronomy Observatory (SARAO).

The other two teams that also participated were Team OptiCompute (mentor: Hendrik van Heerden), consisting of Senatla, Siphesihle Mvelase (Bachelor of Science in Information Technology majoring in Computer Science and Business Management), Ziphezinhle Malinga (Bachelor of Science in Information Technology majoring in Computer Science and Business Management), Ennosse Mkhutyukelwa (Bachelor of Science in Information Technology majoring in Computer Science and Chemistry); and Team KKRT (mentor: Zirke le Roux), consisting of Kananelo Nyakallo Mofokeng (Bachelor of Science in Information Technology majoring in Computer Science and Physics), Boitumelo Ramasike (Bachelor of Science in Information Technology majoring in Computer Science and Business Management), Kamohelo Kolanchu (Bachelor of Science in Information Technology majoring in Computer Science and Mathematics), and Thabang Maokeng (Bachelor of Computer Information Systems).

Highly stressful and demanding

“Since 2017, the UFS has competed in the CHPC Student Cluster Competition, with various successful outcomes. This year was no exception, with Team 5 winning third place at the national round. All teams endured a highly stressful and demanding round where external factors such as load shedding, late and incomplete hardware deliveries, extreme heat, and sleep deprivation played a role,” says Van Eck.

According to its website, the Centre for High-Performance Computing (CHPC), a division of the Council for Scientific and Industrial Research (CSIR), annually hosts a Human Capital Development (HCD) programme for undergraduate students currently enrolled in Science, Technology, Engineering and Mathematics (STEM) fields at South African universities. They undergo training that will take them from zero knowledge of HPC to being able to build mini clusters through various rounds.

The competition is held annually and consists of three rounds: a selection, national, and international round. A team composed of four undergraduate (second-year) students can enter the competition.

This year, twenty teams from eight universities participated in the selection round. Each year, this round is hosted at a different university in the country, with the UFS Bloemfontein Campus playing host this year from 10 to 15 July. During the first round, students were exposed to various technologies and concepts used in HPC and scientific computing. Students were then evaluated according to their technical skills acquired during the selection round, and had to design, present, and defend a cluster design with its network topology.

The national round, for which all three UFS teams qualified, was held at the Kruger National Park from 3 to 8 December.

Travel internationally

According to Van Eck, the students were given a limited budget to procure a small cluster for this round. Students then had to assemble the cluster and start configuring it during this round. After installing and configuring their clusters, students had to install and optimise scientific software. Installing and optimising scientific software is quite challenging. One must consider various technologies such as hardware components, networking, operating systems, compilers, intercommunication between processes, and the functionality of the software.

The winning team in the national round is combined with two members of either the second or third-place winners and two reserves selected from those teams. This team will travel to Austin, Texas, early next year to visit the Texas Advanced Computing Centre (TACC). Students will also undergo more training at Dell Labs in the USA.

The team will compete at the International Supercomputing Conference (ISC) Student Cluster Competition (SCC) against teams from across America, Europe, and Asia. This competition is held in Germany and sees the best international students competing in the final round. The South African teams have won this round on several occasions.

“The competition takes all students out of their comfort zones. The technologies and methodologies they are exposed to are state-of-the-art in theoretical and computational sciences. In the first round, students are trained by industry professionals on concepts they would otherwise never be exposed to. They come into contact with multiple disciplines within IT, engineering, and some scientific fields. The learning curve during this competition is immense, but students who rise to the challenge reap the benefits in the long run. With prizes such as laptops, prize money, and mentorship from the industry, multiple opportunities can be utilised,” says Van Eck.

Exposure to various technologies

Van Eck says even members from teams that do not make it into the top positions can benefit from exposure to various technologies and networking with other delegates. Leveraging knowledge attained during the competition also enhances one's ability to apply knowledge to other parts of one's career.

“To become an HPC specialist, one must master various field-specific domains, and each of these domains can become a career in itself should a student identify a specific field of more interest to them. This type of exposure is usually only experienced once one enters the workforce. It may be difficult and costly to enter a specific domain by that time. Earlier exposure during a competition like this can assist a student in identifying which fields of science, engineering, or IT they would like to focus on and perhaps later specialise in.”

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept